Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Genetics of migraine: where are we now

L. Grangeon, KS. Lange, M. Waliszewska-Prosół, D. Onan, K. Marschollek, W. Wiels, P. Mikulenka, F. Farham, C. Gollion, A. Ducros, European Headache Federation School of Advanced Studies (EHF-SAS)

. 2023 ; 24 (1) : 12. [pub] 20230220

Language English Country England, Great Britain

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc23004138

Migraine is a complex brain disorder explained by the interaction of genetic and environmental factors. In monogenic migraines, including familial hemiplegic migraine and migraine with aura associated with hereditary small-vessel disorders, the identified genes code for proteins expressed in neurons, glial cells, or vessels, all of which increase susceptibility to cortical spreading depression. The study of monogenic migraines has shown that the neurovascular unit plays a prominent role in migraine. Genome-wide association studies have identified numerous susceptibility variants that each result in only a small increase in overall migraine risk. The more than 180 known variants belong to several complex networks of "pro-migraine" molecular abnormalities, which are mainly neuronal or vascular. Genetics has also highlighted the importance of shared genetic factors between migraine and its major co-morbidities, including depression and high blood pressure. Further studies are still needed to map all of the susceptibility loci for migraine and then to understand how these genomic variants lead to migraine cell phenotypes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004138
003      
CZ-PrNML
005      
20230425141121.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s10194-023-01547-8 $2 doi
035    __
$a (PubMed)36800925
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Grangeon, Lou $u Neurology Department, CHU de Rouen, Rouen, France
245    10
$a Genetics of migraine: where are we now / $c L. Grangeon, KS. Lange, M. Waliszewska-Prosół, D. Onan, K. Marschollek, W. Wiels, P. Mikulenka, F. Farham, C. Gollion, A. Ducros, European Headache Federation School of Advanced Studies (EHF-SAS)
520    9_
$a Migraine is a complex brain disorder explained by the interaction of genetic and environmental factors. In monogenic migraines, including familial hemiplegic migraine and migraine with aura associated with hereditary small-vessel disorders, the identified genes code for proteins expressed in neurons, glial cells, or vessels, all of which increase susceptibility to cortical spreading depression. The study of monogenic migraines has shown that the neurovascular unit plays a prominent role in migraine. Genome-wide association studies have identified numerous susceptibility variants that each result in only a small increase in overall migraine risk. The more than 180 known variants belong to several complex networks of "pro-migraine" molecular abnormalities, which are mainly neuronal or vascular. Genetics has also highlighted the importance of shared genetic factors between migraine and its major co-morbidities, including depression and high blood pressure. Further studies are still needed to map all of the susceptibility loci for migraine and then to understand how these genomic variants lead to migraine cell phenotypes.
650    _2
$a lidé $7 D006801
650    _2
$a celogenomová asociační studie $7 D055106
650    12
$a migréna $x genetika $7 D008881
650    12
$a migréna s aurou $7 D020325
650    12
$a šířící se kortikální deprese $x fyziologie $7 D013181
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Lange, Kristin Sophie $u Neurology Department, Charité - Universitätsmedizin Berlin, Berlin, Germany $u Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin, Berlin, Germany
700    1_
$a Waliszewska-Prosół, Marta $u Department of Neurology, Wrocław Medical University, Wrocław, Poland
700    1_
$a Onan, Dilara $u Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Ankara, Turkey
700    1_
$a Marschollek, Karol $u Department of Neurology, Wrocław Medical University, Wrocław, Poland
700    1_
$a Wiels, Wietse $u Department of Neurology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
700    1_
$a Mikulenka, Petr $u Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Farham, Fatemeh $u Headache Department, Iranian Centre of Neurological Researchers, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Gollion, Cédric $u Neurology Department, CHU de Toulouse, Toulouse, France
700    1_
$a Ducros, Anne $u Neurology Department, CHU de Montpellier, 80 avenue Augustin Fliche, 34295, Montpellier, France. a-ducros@chu-montpellier.fr
710    2_
$a European Headache Federation School of Advanced Studies (EHF-SAS)
773    0_
$w MED00005758 $t The journal of headache and pain $x 1129-2377 $g Roč. 24, č. 1 (2023), s. 12
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36800925 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141117 $b ABA008
999    __
$a ok $b bmc $g 1924665 $s 1190347
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 24 $c 1 $d 12 $e 20230220 $i 1129-2377 $m The Journal of headaches and pain $n J Headache Pain $x MED00005758
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Archiving options